Tolmie Stratton B, Gibbons Robert D, Anderson Allen S, Khush Kiran K, Chhikara Kaveri, Churpek Matthew, Parker William F
Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, USA.
Department of Medicine and Public Health Sciences, The University of Chicago, Chicago, Illinois, USA.
JACC Heart Fail. 2025 Jul;13(7):102480. doi: 10.1016/j.jchf.2025.02.026. Epub 2025 Jun 4.
In 2018, the U.S. heart allocation policy underwent a major change designed to increase the transplantation of the most medically urgent candidates.
This study aims to determine the association between the 2018 policy change and the survival benefit of heart transplantation.
Observational study of the 23,043 U.S. adult heart transplant candidates listed before the policy change (October 2013 to October 2016) and a seasonally matched cohort listed after the policy change (October 2018 to October 2021). The main study outcome was the survival benefit of transplantation as defined by the increase in average days alive within 3 years following transplantation. The authors estimated survival with and without heart transplantation using a mixed-effects Cox proportional hazards model with transplant and status as time-dependent covariates and a random center-level intercept and transplant effect.
Of the 11,022 candidates in the pre-policy cohort and 12,021 candidates in the post-policy cohort across 111 centers, 7,165 (65.0%) in the pre-policy cohort and 8,941 (74.4%) in the post-policy cohort underwent heart transplantation. Absolute 3-year survival benefit among the highest priority status candidates more than doubled after the policy change (327.8 days pre-policy vs 699.8 days post-policy; P < 0.001). All statuses experienced a positive long-run survival benefit of transplantation. The average 3-year survival benefit across all statuses increased from 217.1 days to 241.2 days per donor heart (P < 0.001). Overall, during the first 3 years after implementation, the 2018 heart allocation policy change was associated with an additional 1,645 life-years saved from transplantation (4,259 vs 5,904; P < 0.001).
The 2018 heart allocation policy change has led to better stratification and prioritization of candidates by clinical acuity, resulting in higher survival benefit of transplantation performed. Combined with higher transplantation rates, the 2018 heart allocation policy has saved thousands of life-years and achieved one of its major goals.
2018年,美国心脏分配政策发生重大变化,旨在增加医学上最紧急候选者的移植数量。
本研究旨在确定2018年政策变化与心脏移植生存获益之间的关联。
对政策变化前(2013年10月至2016年10月)登记的23043名美国成年心脏移植候选者以及政策变化后(2018年10月至2021年10月)按季节匹配的队列进行观察性研究。主要研究结局是移植的生存获益,定义为移植后3年内平均存活天数的增加。作者使用混合效应Cox比例风险模型估计有或无心脏移植的生存率,将移植和状态作为时间依赖性协变量,并设置随机中心水平截距和移植效应。
在111个中心的政策前队列中的11022名候选者和政策后队列中的12021名候选者中,政策前队列中有7165名(65.0%)、政策后队列中有8941名(74.4%)接受了心脏移植。政策变化后,最高优先级候选者的绝对3年生存获益增加了一倍多(政策前为327.8天,政策后为699.8天;P<0.001)。所有优先级的候选者都从移植中获得了长期生存获益。所有优先级的平均3年生存获益从每个供体心脏217.1天增加到241.2天(P<0.001)。总体而言,在实施后的前3年中,2018年心脏分配政策变化与移植额外挽救1645个生命年相关(4259个生命年对5904个生命年;P<0.001)。
2018年心脏分配政策变化使候选者能够根据临床急症程度得到更好的分层和优先排序,从而提高了移植的生存获益。结合更高的移植率,2018年心脏分配政策挽救了数千个生命年,实现了其主要目标之一。